Zobrazeno 1 - 10
of 56
pro vyhledávání: '"João M. Frazão"'
Autor:
Luciano Pereira, André Weigert, Maria Teresa Mendes, Manuel Augusto Gonçalves Amoedo, Catarina Meng, Marco Marques, João M. Frazão
Publikováno v:
Nefrología. 43:197-203
There is scarce clinical experience with etelcalcetide in patients with secondary hyperparathyroidism uncontrolled with cinacalcet. The effect of etelcalcetide on serum sclerostin levels remains to be clarified.Prospective cohort study in prevalent h
Autor:
Juliana Macêdo Magalhães, Luciano Pereira, João M. Frazão, Janete Quelhas-Santos, Sandra Martins, Catarina Carvalho, Ricardo Neto
Publikováno v:
Clinical Kidney Journal
Background Disordered mineral and bone metabolism is a common complication of chronic kidney disease (CKD). Bone biopsy remains the gold standard tool for evaluating renal osteodystrophy (ROD), but it is an invasive procedure. Despite a growing inter
Autor:
Luciano Pereira, João M. Frazão
Publikováno v:
Clinica Chimica Acta. 508:221-227
Vascular wall calcification (VC) is highly prevalent in patients with chronic kidney disease (CKD). In CKD, VC is more frequent and severe than in the general population and it is associated with increased cardiovascular mortality and morbidity. In t
Autor:
João M. Frazão, Ricardo Neto
Publikováno v:
Clinical Kidney Journal
Background Disordered bone and mineral metabolism are a common complication of chronic kidney disease (CKD). Phosphate binders are often prescribed in advanced CKD, when hyperphosphataemia develops. Little is known about the role of these drugs in ea
Autor:
Wisam Al Badr, Werner Kleophas, Szymon Brzosko, Partha Pratim Das, Fatima Silva, João M. Frazão, Maciej Drozdz, Stefan H. Jacobson
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
Background The transition from chronic kidney disease stage 5 to initiation of hemodialysis has gained increased attention in recent years as this period is one of high risk for patients with an annual mortality rate exceeding 20%. Morbidity and mort
Autor:
José Silva-Cardoso, Dulce Brito, Paulo Bettencourt, Cândida Fonseca, João M. Frazão, Aníbal Ferreira, Patrícia Branco
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Heart Failure Reviews
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Heart Failure Reviews
© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be96210134355130854f40c94c9dc1f9
https://hdl.handle.net/10362/113799
https://hdl.handle.net/10362/113799
Autor:
Luciano Pereira, Ricardo Neto, João M. Frazão, Janete Quelhas-Santos, Juliana Macêdo Magalhães
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 10, p e0258284 (2021)
PLoS ONE, Vol 16, Iss 10, p e0258284 (2021)
Background Vascular calcification (VC) is a common finding in chronic kidney disease (CKD) patients and predicts subsequent cardiovascular morbidity and mortality in this population. Vascular calcification is linked to disordered mineral metabolism a
Autor:
Mahesh Krishnan, Fatima Silva, Maciej Drozdz, Abdulkareem Alsuwaida, Werner Kleophas, Szymon Brzosko, Fredrik K. Johansson, Stefan H. Jacobson, João M. Frazão, André Weigert
Publikováno v:
Clinical Kidney Journal
BackgroundWomen of all ages and elderly patients of both genders comprise an increasing proportion of the haemodialysis population. Worldwide, significant differences in practice patterns and treatment results exist between genders and among younger
Autor:
Szymon Brzosko, Fredrik K. Johansson, André Weigert, Fatima Silva, Abdulkareem Alsuwaida, Stefan H. Jacobson, João M. Frazão, Mahesh Krishnan, Maciej Drozdz, Werner Kleophas
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-10 (2019)
BMC Nephrology
BMC Nephrology
Background The optimal treatment algorithm for iron therapy and the use of erythropoiesis-stimulating agents (ESA) in anemic hemodialysis (HD) patients has not been established. Hemoglobin (Hb) target levels can be achieved through more frequent intr
Autor:
Ana Pereira, João M. Frazão
Publikováno v:
Portuguese Journal of Nephrology & Hypertension. 34
Ao longo do seculo passado, enormes avancos cientificos permitiram melhor compreender a fisiopatologia da doenca mineral e ossea, na doenca renal cronica (DRC). De igual forma, o desenvolvimento de novas terapias farmacologicas, a par com alteracoes